Siponimod vs placebo
Relapse · people with multiple sclerosis
It is very uncertain whether siponimod changes number of participants with relapses at 6 months compared with placebo (very low certainty).
1 finding from 1 review
- RR 0.38 [0.15, 1]1 study · 94 participantsVery low